SEC Form 4 · accession 0001192482-18-000492
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
James Early
Officer — Chief Financial Officer
Period of report
Dec 5, 2018
Accepted (ET)
Dec 6, 2018 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 14,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.08 | Dec 5, 2018 | A | 15,000 | A | — | Dec 5, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer.